K
Koji Tomaru
Researcher at Yokohama City University
Publications - 11
Citations - 160
Koji Tomaru is an academic researcher from Yokohama City University. The author has contributed to research in topics: Lung cancer & Chemotherapy. The author has an hindex of 6, co-authored 11 publications receiving 140 citations.
Papers
More filters
Journal ArticleDOI
Proteasome-dependent degradation of α-catenin is regulated by interaction with ARMc8α
Takeyuki Suzuki,Atsuhisa Ueda,Nobuaki Kobayashi,Jun Yang,Koji Tomaru,Masaki Yamamoto,Mitsuhiro Takeno,Yoshiaki Ishigatsubo +7 more
TL;DR: It is concluded that ARMc8alpha associates with alpha-catenin and up-regulates its degradation, which resulted in rapid degradation of the exogenous alpha-catsine and prolonged the half-life of alpha- catenin.
Journal ArticleDOI
Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan.
Nobuyuki Horita,Naoki Miyazawa,T Yoshiyama,Takashi Sato,M Yamamoto,Koji Tomaru,M Masuda,Ken Tashiro,M. Sasaki,Satoshi Morita,Tetsuji Kaneko,Yoshiaki Ishigatsubo +11 more
TL;DR: This retrospective cohort study conducted in Japan comprised the development and validation of a tuberculosis prognostic score among patients with newly diagnosed smear-positive non-multidrug-resistant pulmonary tuberculosis without human immunodeficiency virus infection.
Journal ArticleDOI
Armadillo Repeat Containing 8α Binds to HRS and Promotes HRS Interaction with Ubiquitinated Proteins
Koji Tomaru,Atsuhisa Ueda,Takeyuki Suzuki,Nobuaki Kobayashi,Jun J. Yang,Masaki Yamamoto,Mitsuhiro Takeno,Takeshi Kaneko,Yoshiaki Ishigatsubo +8 more
TL;DR: Findings suggest that HRS mediates protein endosomal trafficking partly through its interaction with ARMc8α, which promoted the interaction of HRS with various ubiquitinated proteins through the ubiquitin-interacting motif.
Journal ArticleDOI
Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis
TL;DR: Some trials have been conducted to compare long‐acting muscarinic antagonist (LAMA) + long‐acting beta agonist (LABA) versus LABA + inhaled corticosteroids (ICS) for chronic obstructive pulmonary disease (COPD), but no meta‐analysis was reported.
Journal ArticleDOI
Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: A meta‐analysis
TL;DR: This data indicates that among the three alleles of vitamin D binding protein, or group‐specific (GC) components, some have suggested that having GC‐1F and GC‐2 alleles was associated with a risk of COPD, but no meta‐analysis has been conducted.